DV
Dividend Vision

UTHR — United Therapeutics Corp.

United Therapeutics Corp. (UTHR)

Total return is 8100.6% over the past 27.2 years, 7272.2 points ahead of SPY at 828.4%. Its deepest 1-year drawdown was 16.0%.

This is a single-stock equity holding in United Therapeutics Corp., a biopharmaceutical company focused on therapeutic treatments. The stock does not currently pay dividends, resulting in a N/A distribution rate, and lacks the diversification typical of ETFs, instead functioning as a direct equity position in a single issuer. This holding appeals primarily to growth-oriented investors seeking exposure to the biopharmaceutical sector rather than income-focused dividend investors.

UTHR key facts

Asset type
Stock
Asset class
Equity
Inception date
06/17/1999
Distribution frequency
None
Last close
$499.73
Market cap
$21,433,765,888
Average volume
473000.0
Beta
0.564
Payout ratio
0.0
P/E ratio
17.8986
Forward P/E
19.2678
EPS
$27.92